{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:17:39Z","timestamp":1780471059822,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Luzern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the prognostic and predictive significance of supradiaphragmatic lymph node (SDLN) positivity detected by 18F-fluorodeoxyglucose positron emission tomography\/computed tomography (18F-FDG PET\/CT) in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis was conducted according to PRISMA 2020 guidelines and registered with PROSPERO. Studies reporting on overall survival (OS), progression-free survival (PFS), and complete cytoreduction (R0) in patients with and without 18F-FDG PET\/CT-detected SDLN metastases were identified through comprehensive database searches conducted on December 18, 2024. Data from five retrospective, single-center studies comprising a total of 605 patients were included in the quantitative synthesis. Meta-analyses were performed using a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SDLN positivity on 18F-FDG PET\/CT was significantly associated with worse survival outcomes and lower resection rates. The pooled hazard ratio (HR) for OS was 1.60 (95% CI 1.19\u20132.25,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) and for PFS 1.53 (95% CI 1.19\u20131.96;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0009), indicating poorer prognosis in SDLN-positive patients. The odds of achieving complete cytoreduction were significantly reduced in this group (OR\u2009=\u20090.32, 95% CI 0.15\u20130.68,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). While heterogeneity was low for progression-free and overall survival (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%), moderate heterogeneity was observed in the analysis of complete cytoreduction (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200954%). None of the included studies provided histologic confirmation of 18F-FDG PET\/CT-positive SDLNs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>18F-FDG PET\/CT-detected SDLN positivity is associated with worse survival and lower resectability in advanced ovarian cancer. Due to lacking histologic confirmation and retrospective data, prospective validation is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-025-08234-w","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:38:59Z","timestamp":1761766739000},"page":"1927-1935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic and predictive value of supradiaphragmatic lymph node involvement detected by 18F-FDG PET\/CT in advanced ovarian cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"312","author":[{"given":"Christian","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Peikert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Brambs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"6","key":"8234_CR1","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer 115(6):1234\u20131244","journal-title":"Cancer"},{"issue":"6","key":"8234_CR2","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/01.AOG.0000220516.34053.48","volume":"107","author":"S Bhoola","year":"2006","unstructured":"Bhoola S, Hoskins WJ (2006) Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 107(6):1399\u20131410","journal-title":"Obstet Gynecol"},{"issue":"8","key":"8234_CR3","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1016\/S1470-2045(22)00139-5","volume":"23","author":"I Vergote","year":"2022","unstructured":"Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz JE et al (2022) Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Lancet Oncol 23(8):e374\u2013e384","journal-title":"Lancet Oncol"},{"issue":"4","key":"8234_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","volume":"29","author":"N Colombo","year":"2019","unstructured":"Colombo N, Sessa C, Bois Ad, Ledermann J, McCluggage W, McNeish I et al (2019) ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer 29(4):728\u2013760","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"8234_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/ijgc-2021-002565","volume":"31","author":"D Timmerman","year":"2021","unstructured":"Timmerman D, Planchamp F, Bourne T, Landolfo C, du Bois A, Chiva L et al (2021) ESGO\/ISUOG\/IOTA\/ESGE consensus statement on pre-operative diagnosis of ovarian tumors. Int J Gynecol Cancer 31(7):961\u2013982","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"8234_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1186\/s12885-018-5067-1","volume":"18","author":"IO Lee","year":"2018","unstructured":"Lee IO, Lee JY, Kim HJ, Nam EJ, Kim S, Kim SW et al (2018) Prognostic significance of supradiaphragmatic lymph node metastasis detected by (18)F-FDG PET\/CT in advanced epithelial ovarian cancer. BMC Cancer 18(1):1165","journal-title":"BMC Cancer"},{"issue":"3","key":"8234_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ygyno.2009.12.008","volume":"116","author":"S Risum","year":"2010","unstructured":"Risum S, H\u00f8gdall C, Loft A, Berthelsen AK, H\u00f8gdall E, Nedergaard L et al (2010) Does the use of diagnostic PET\/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol 116(3):395\u2013398","journal-title":"Gynecol Oncol"},{"issue":"1","key":"8234_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","volume":"126","author":"J Hynninen","year":"2012","unstructured":"Hynninen J, Auranen A, Carp\u00e9n O, Dean K, Sepp\u00e4nen M, Kemppainen J et al (2012) FDG PET\/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. Gynecol Oncol 126(1):64\u201368","journal-title":"Gynecol Oncol"},{"issue":"3","key":"8234_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ygyno.2013.09.024","volume":"131","author":"R Fruscio","year":"2013","unstructured":"Fruscio R, Sina F, Dolci C, Signorelli M, Crivellaro C, Dell\u2019Anna T et al (2013) Preoperative 18F-FDG PET\/CT in the management of advanced epithelial ovarian cancer. Gynecol Oncol 131(3):689\u2013693","journal-title":"Gynecol Oncol"},{"key":"8234_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejogrb.2024.02.028","volume":"296","author":"C Braun","year":"2024","unstructured":"Braun C, Gr\u00fcnig H, Peikert J, Strobel K, Christmann-Schmid C, Brambs C (2024) Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer? Eur J Obstet Gynecol Reprod Biol 296:13\u201319","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"8234_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0009-9260(97)80034-7","volume":"52","author":"BJ Holloway","year":"1997","unstructured":"Holloway BJ, Gore ME, A\u2019Hern RP, Parsons C (1997) The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol 52(9):692\u2013697","journal-title":"Clin Radiol"},{"issue":"2","key":"8234_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygyno.2015.05.007","volume":"138","author":"O Raban","year":"2015","unstructured":"Raban O, Peled Y, Krissi H, Goldberg N, Aviram A, Sabah G et al (2015) The significance of paracardiac lymph-node enlargement in patients with newly diagnosed stage IIIC ovarian cancer. Gynecol Oncol 138(2):259\u2013262","journal-title":"Gynecol Oncol"},{"issue":"6","key":"8234_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/IGC.0b013e3181e833f5","volume":"20","author":"V Kolev","year":"2010","unstructured":"Kolev V, Mironov S, Mironov O, Ishill N, Moskowitz CS, Gardner GJ et al (2010) Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. Int J Gynecol Cancer 20(6):979\u2013984","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"8234_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygyno.2018.11.001","volume":"152","author":"S Prader","year":"2019","unstructured":"Prader S, Vollmar N, du Bois A, Heitz F, Schneider S, Ataseven B et al (2019) Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer. Gynecol Oncol 152(1):76\u201381","journal-title":"Gynecol Oncol"},{"issue":"8","key":"8234_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/aogs.13835","volume":"99","author":"AK Luger","year":"2020","unstructured":"Luger AK, Steinkohl F, Aigner F, Jaschke W, Marth C, Zeimet AG et al (2020) Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer. Acta Obstet Gynecol Scand 99(8):1092\u20131099","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"8234_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4274\/tjod.12144","volume":"15","author":"J Raoufi","year":"2018","unstructured":"Raoufi J, \u0130\u015fcan SC, Hanedan C, \u00d6zkan EE, \u00c7er\u00e7i SS, Erdemo\u011flu E (2018) Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography\/computed tomography in gynecologic cancers. J Turk Soc Obstet Gynecol 15(2):99\u2013104","journal-title":"J Turk Soc Obstet Gynecol"},{"issue":"3","key":"8234_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00259-011-1984-9","volume":"39","author":"AS Bats","year":"2012","unstructured":"Bats AS, Hugonnet F, Huchon C, Bensaid C, Pierquet-Ghazzar N, Faraggi M et al (2012) Prognostic significance of mediastinal 18F-FDG uptake in PET\/CT in advanced ovarian cancer. Eur J Nucl Med Mol Imaging 39(3):474\u2013480","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"8234_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299205","volume":"19","author":"K Park","year":"2024","unstructured":"Park K, Kwon JY, Song JM, Pyeon SY, Lee SH, Chung YS et al (2024) Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer. PLoS ONE 19(5):e0299205","journal-title":"PLoS ONE"},{"issue":"7","key":"8234_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/IGC.0b013e3182606ecb","volume":"22","author":"S Risum","year":"2012","unstructured":"Risum S, Loft A, Engelholm SA, H\u00f8gdall E, Berthelsen AK, Nedergaard L et al (2012) Positron emission tomography\/computed tomography predictors of overall survival in stage IIIC\/IV ovarian cancer. Int J Gynecol Cancer 22(7):1163\u20131169","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"8234_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","volume":"108","author":"S Risum","year":"2008","unstructured":"Risum S, H\u00f8gdall C, Loft A, Berthelsen AK, H\u00f8gdall E, Nedergaard L et al (2008) Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography\/computed tomography\u2013a prospective study. Gynecol Oncol 108(2):265\u2013270","journal-title":"Gynecol Oncol"},{"issue":"12","key":"8234_CR21","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.ejso.2022.08.026","volume":"48","author":"U Leone Roberti Maggiore","year":"2022","unstructured":"Leone Roberti Maggiore U, Bogani G, Martinelli F, Signorelli M, Chiappa V, Lopez S et al (2022) Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer. Eur J Surg Oncol 48(12):2551\u20132557","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"8234_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380(9):822\u2013832","journal-title":"N Engl J Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08234-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:07:16Z","timestamp":1765804036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08234-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8234"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08234-w","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}